Expanded Access for Pembrolizumab (MK-3475)

Clinical trial NCT03311542 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03311542
Sponsor: Center Trials & Treatment
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Melanoma (Skin)Melanoma Recurrent Glioblastoma Multiforme Glioblastoma by Gene Expression Profile Glioma of Brain

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.